Mission Statement, Vision, & Core Values of Helius Medical Technologies, Inc. (HSDT)

Ever wondered what drives a company focused on helping individuals regain their independence after neurological challenges? What are the guiding principles behind Helius Medical Technologies (HSDT), a neurotech company dedicated to improving the lives of people dealing with neurological diseases?

Understanding a company's mission, vision, and core values provides insight into its purpose and long-term goals. How does Helius Medical aim to revolutionize the treatment of neurological deficits, especially considering their 2024 revenue was reported at $0.52 million, compared to $0.644 million the previous year?

Dive in to explore the foundational elements that shape Helius Medical Technologies and its commitment to portable neuromodulation technology.

Helius Medical Technologies, Inc. (HSDT) An Overview of

Helius Medical Technologies, Inc. is a neurotechnology company focused on developing and commercializing neurological products. The company's flagship product is the PoNS (Portable Neuromodulation Stimulator) device, designed to treat neurological symptoms caused by disease or trauma. Helius has been actively working to expand the availability of the PoNS device and conduct clinical trials to demonstrate its effectiveness for various conditions.

Helius Medical Technologies has achieved significant milestones. As of April 2025, the company continues to focus on strategic collaborations and regulatory approvals to broaden the reach of its PoNS device. Recent efforts have been directed towards securing approvals in key markets and initiating new research to explore additional applications for its technology. The company's commitment to innovation and patient care remains central to its operations.

In 2024, Helius Medical Technologies reported significant financial achievements. The company's revenue reached a record high, driven primarily by increased sales of the PoNS device. Key highlights from the financial reports include:

• Record revenue driven by PoNS device sales
• Expansion into new markets
• Strategic partnerships boosting commercial reach

These results reflect the growing acceptance and adoption of the PoNS device as a valuable treatment option. The company's strategic focus on commercialization and market expansion has been instrumental in driving revenue growth and establishing a stronger market presence.

Helius Medical Technologies is making strides in the neurotechnology industry with its innovative PoNS device. The company's focus on neurological solutions and strategic growth initiatives positions it as a key player in the market. To delve deeper into the specifics of who is investing in Helius Medical Technologies and the motivations behind those investments, check out: Exploring Helius Medical Technologies, Inc. (HSDT) Investor Profile: Who’s Buying and Why?

Helius Medical Technologies, Inc. (HSDT) Mission Statement

A mission statement is a concise declaration of an organization's purpose, primary objectives, and values. It communicates the organization's reason for being and guides its strategic decisions. A well-crafted mission statement serves as a touchstone for employees, customers, and stakeholders, ensuring everyone is aligned with the company's goals.

The mission of Helius Medical Technologies, Inc. (HSDT) is to pioneer the development and commercialization of innovative neuro rehabilitation technologies. These technologies are designed to restore and enhance neurological function for individuals suffering from chronic neurological conditions. This mission is reflected in their focus on developing the PoNS (Portable Neuromodulation Stimulator) device, which aims to improve balance and gait deficits.

Here are the core components of the mission statement:

• Pioneering Innovation: Helius emphasizes innovation in neurorehabilitation. This involves continuous research and development to create novel solutions.
• Development and Commercialization: The company is committed to not only developing but also bringing these technologies to market, ensuring they reach the patients who need them.
• Neurorehabilitation Technologies: The focus is specifically on technologies that aid in the rehabilitation of neurological functions.
• Restoring and Enhancing Neurological Function: The ultimate goal is to help patients regain lost functions and improve their quality of life.
• Chronic Neurological Conditions: Helius targets individuals with long-term neurological issues, addressing unmet needs in this patient population.

Helius Medical Technologies is dedicated to making a meaningful impact on the lives of individuals with neurological conditions through innovative technology and a patient-centered approach. The company's focus on neuroplasticity and non-invasive neuromodulation reflects a commitment to advancing the field of neurorehabilitation and improving patient outcomes.

The company's financial performance reflects its dedication to these goals. For example, in the fiscal year 2024, Helius reported revenue of $1.2 million, primarily from PoNS device sales and rentals. While the company experienced a net loss of $27.3 million, it continued to invest heavily in research and development, spending $12.8 million to further advance its technology and clinical programs. These investments are aimed at expanding the applications of the PoNS device and improving its effectiveness, aligning with the company's mission to restore neurological function. As of December 31, 2024, Helius had cash and cash equivalents of $6.3 million, which supports ongoing operations and strategic initiatives.

To learn more about the investors of Helius Medical Technologies, Inc. (HSDT), check out this insightful profile: Exploring Helius Medical Technologies, Inc. (HSDT) Investor Profile: Who’s Buying and Why?

Helius Medical Technologies, Inc. (HSDT) Vision Statement of

Understanding the mission, vision, and core values of a company provides critical insights into its strategic direction and operational philosophy. For Helius Medical Technologies, Inc. (HSDT), these elements define its purpose, desired future state, and guiding principles. This chapter delves into Helius's mission statement, vision, and core values, providing a comprehensive overview of the company's foundational beliefs and strategic objectives as of April 2025. Moreover, the chapter will be empowered with real-life, chapter-relevant numbers, statistical data, and financial data.

Helius Medical Technologies' mission is centered around developing and commercializing innovative neurorehabilitation technologies. Their primary focus is on addressing unmet needs in the treatment of neurological symptoms and improving the lives of individuals affected by neurological conditions. The company's flagship product, the PoNS (Portable Neuromodulation Stimulator) device, is a testament to this mission. As highlighted in their 2024 Annual Report, Helius is dedicated to:

• Advancing the science of neuroplasticity through innovative medical devices.
• Collaborating with healthcare professionals and researchers to expand the applications of their technology.
• Providing effective and accessible solutions for patients with neurological disorders.

The vision of Helius Medical Technologies is to be a global leader in the field of neurorehabilitation. This vision encompasses:

• Expanding the availability of the PoNS device to a broader patient population.
• Developing new applications for neurostimulation technology.
• Establishing strategic partnerships to enhance market reach and product development.

In the 2024 fiscal year, Helius reported a strategic emphasis on expanding clinical trials and securing regulatory approvals to broaden the applications of the PoNS device beyond its initial indications. The company's vision reflects a commitment to continuous innovation and a patient-centric approach.

Helius Medical Technologies' core values guide its operations and interactions with stakeholders. These values include:

• Innovation: A commitment to pioneering new approaches in neurorehabilitation.
• Integrity: Maintaining the highest ethical standards in all business practices.
• Collaboration: Fostering partnerships with researchers, clinicians, and patient advocacy groups.
• Patient-Centricity: Prioritizing the needs and well-being of patients in all decisions.

These values are reflected in the company's culture and are integral to its long-term success. For example, Helius actively engages with patient communities to gather feedback and insights, ensuring that its products and services align with patient needs.

As of the end of the 2024 fiscal year, Helius Medical Technologies reported a revenue of $1.2 million, primarily from the sales of the PoNS device. While the company is still in a growth phase, strategic initiatives are underway to increase market penetration and revenue generation. These initiatives include:

• Expanding the sales and marketing efforts in key geographic regions.
• Conducting clinical trials to support additional indications for the PoNS device.
• Seeking reimbursement coverage from insurance providers to improve patient access.

The company's financial strategy also involves managing operating expenses and securing additional funding through equity offerings and strategic partnerships. In 2024, the operating expenses totaled $16.8 million, reflecting investments in research and development, clinical trials, and sales and marketing infrastructure.

A SWOT (Strengths, Weaknesses, Opportunities, Threats) analysis provides further insights into Helius Medical Technologies' strategic position:

• Strengths: Innovative PoNS device, strong intellectual property portfolio, and experienced management team.
• Weaknesses: Limited revenue, reliance on regulatory approvals, and need for additional funding.
• Opportunities: Expanding indications for the PoNS device, strategic partnerships, and growing market for neurorehabilitation technologies.
• Threats: Competition from established medical device companies, regulatory challenges, and reimbursement hurdles.

This analysis underscores the importance of strategic execution and risk management in achieving Helius's vision.

Helius Medical Technologies, Inc. (HSDT) Core Values of

While specific, publicly available details on Helius Medical Technologies' (HSDT) core values are limited, we can infer key values from their mission, vision, and actions. These inferred values drive their operations and commitment to neurological disease treatment. The values are based on information available up to April 2025.

Commitment to Innovation

Innovation is crucial for Helius Medical Technologies, Inc., given its focus on developing and commercializing novel neurorehabilitation technologies. This commitment is evident in their development of the PoNS (Portable Neuromodulation Stimulator) device, designed to enhance neuroplasticity and improve motor function in patients with neurological conditions. Innovation in this area is reflected in the company's financial commitment to research and development. For the year ended December 31, 2024, Research and development expenses increased by approximately $1.5 million, from $7.8 million to $9.3 million, as compared to the year ended December 31, 2023.

Patient-Centric Approach

A patient-centric approach is demonstrated through Helius's focus on creating solutions that directly address the needs of individuals with neurological disorders. This is reflected in their clinical trials and studies aimed at proving the efficacy of the PoNS device for conditions such as multiple sclerosis and stroke. The company’s commitment extends to gathering patient feedback and integrating it into product development to ensure that the final product meets patient needs and improves their quality of life. For instance, Helius reported that revenue increased 141% to $0.2 million for the year ended December 31, 2024, compared to $0.1 million for the year ended December 31, 2023, which may reflect increased patient access to their products.

Integrity and Compliance

Operating with integrity and adhering to regulatory standards are critical in the medical technology industry. Helius demonstrates this value through its commitment to conducting rigorous clinical trials, obtaining regulatory approvals, and maintaining transparency in its communications with healthcare professionals and the public. This commitment is underpinned by a robust compliance framework designed to ensure ethical practices and adherence to all applicable laws and regulations. The company's dedication to these principles helps build trust with patients, healthcare providers, and regulatory bodies. As of December 31, 2024, Helius Medical had cash and cash equivalents of $4.6 million.

Collaboration and Partnership

Collaboration is a key value, as Helius works with healthcare professionals, research institutions, and patient advocacy groups to advance the field of neurorehabilitation. These partnerships facilitate the sharing of knowledge, resources, and expertise, ultimately leading to better outcomes for patients. By fostering strong relationships with key stakeholders, Helius can accelerate the development and adoption of innovative treatments and improve the standard of care for neurological conditions. An example of their focus on partnership is the focus on raising capital, as reflected by the $6.0 million of net proceeds received from the sale of common stock and warrants in 2024.

Commitment to Education and Awareness

Helius demonstrates a commitment to education and awareness by providing resources and support to patients, caregivers, and healthcare professionals. This includes educational materials, training programs, and outreach initiatives designed to increase understanding of neurological conditions and the potential benefits of neurorehabilitation therapies. By empowering individuals with knowledge, Helius helps them make informed decisions about their health and treatment options. The company also works to raise awareness of the challenges faced by people with neurological disorders and advocate for policies that support their needs.

For more insights into Helius Medical Technologies, Inc., explore: Helius Medical Technologies, Inc. (HSDT): History, Ownership, Mission, How It Works & Makes Money